One of the major challenges in modern vaccinology is to engineer vectors that are highly infectious, yet don’t cause illness. Now scientists have unveiled what may prove a winning strategy in the fight against infant bacterial pneumonia.
One of the major challenges in modern vaccinology is to engineer vectors that are highly infectious, yet don’t cause illness. Now scientists have unveiled what may prove a winning strategy in the fight against infant bacterial pneumonia.